FDA Inspection 1037093 — Vitalant

Vitalant — FEI 1034631

The FDA completed an inspection of Vitalant on January 9, 2018 in Memphis, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 9, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Memphis, TN (United States)

Citations

IDCFRDescription
1809321 CFR 630.10(g)(1)Proof Of Identity
4121 CFR 606.40(a)(1)Provide space for examination